CFO of Adv. Bionics & Sirna
(Two > 1 billion Exits)
Mr. Schmieg is a “C” level executive with 35 years of business experience and has a diversified background in the global life sciences industry. As a hands-on leader, Martin’s early career focused on financial management responsibilities serving as Chief Financial Officer for Cytometrics, Inc.; Advanced Bionics Corporation; Sirna Therapeutics, Inc.; and Isolagen, Inc. Martin has an exceptional ability and track record of successful exists. With Advanced Bionics, he was the financial architect of the company’s sale to Boston Scientific for $4.2 billion. While at Sirna Therapeutics, he co-developed the company's strategic plan with the venture owners, which led to the company's acquisition by Merck & Co for $1.3 billion. His cumulative debt and equity financing and transaction experience exceeds $6 billion.